{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T23:22:33Z","timestamp":1788218553151,"version":"build-2803163510"},"reference-count":134,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,19]],"date-time":"2020-08-19T00:00:00Z","timestamp":1597795200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81701144"],"award-info":[{"award-number":["81701144"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.biopha.2020.110656","type":"journal-article","created":{"date-parts":[[2020,8,22]],"date-time":"2020-08-22T05:40:41Z","timestamp":1598074841000},"page":"110656","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"special_numbering":"C","title":["Dysfunction of the neurovascular unit in diabetes-related neurodegeneration"],"prefix":"10.1016","volume":"131","author":[{"given":"Caochong","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunxiang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John H.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hefeng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5616-0394","authenticated-orcid":false,"given":"Anwen","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2020.110656_bib0005","doi-asserted-by":"crossref","first-page":"107843","DOI":"10.1016\/j.diabres.2019.107843","article-title":"Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9(th) edition","volume":"157","author":"Saeedi","year":"2019","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.biopha.2020.110656_bib0010","series-title":"Diabetes and Global Ageing Among 65-99-Year-Old Adults: Findings From the International Diabetes Federation Diabetes Atlas","first-page":"108078","author":"A, S","year":"2020"},{"issue":"5","key":"10.1016\/j.biopha.2020.110656_bib0015","doi-asserted-by":"crossref","first-page":"963","DOI":"10.2337\/dc17-1962","article-title":"Global economic burden of diabetes in adults: projections from 2015 to 2030","volume":"41","author":"C, B","year":"2018","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.biopha.2020.110656_bib0020","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19020481","article-title":"The impact of aging on cardio and cerebrovascular diseases","volume":"19","author":"Izzo","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"37 Suppl 1","key":"10.1016\/j.biopha.2020.110656_bib0025","first-page":"S81","article-title":"Diagnosis and classification of diabetes mellitus","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.biopha.2020.110656_bib0030","doi-asserted-by":"crossref","first-page":"109767","DOI":"10.1016\/j.biopha.2019.109767","article-title":"A review on the potential of Resveratrol in prevention and therapy of diabetes and diabetic complications","volume":"125","author":"Huang","year":"2020","journal-title":"Biomed. Pharmacother."},{"issue":"4","key":"10.1016\/j.biopha.2020.110656_bib0035","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21041250","article-title":"Healthy effects of plant polyphenols: molecular mechanisms","volume":"21","author":"Leri","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.biopha.2020.110656_bib0040","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1161\/HYP.0000000000000053","article-title":"Impact of hypertension on cognitive function: a scientific statement from the american heart association","volume":"68","author":"Iadecola","year":"2016","journal-title":"Hypertension"},{"issue":"7628","key":"10.1016\/j.biopha.2020.110656_bib0045","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/539179a","article-title":"Neurodegenerative diseases","volume":"539","author":"Heemels","year":"2016","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.biopha.2020.110656_bib0050","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1089\/rej.2011.1289","article-title":"Can Alzheimer disease be a form of type 3 diabetes?","volume":"15","author":"Accardi","year":"2012","journal-title":"Rejuvenation Res."},{"issue":"3","key":"10.1016\/j.biopha.2020.110656_bib0055","doi-asserted-by":"crossref","first-page":"418","DOI":"10.2174\/18715273113126660155","article-title":"Does Parkinson's disease and type-2 diabetes mellitus present common pathophysiological mechanisms and treatments?","volume":"13","author":"Lima","year":"2014","journal-title":"CNS Neurol. Disord. Drug Targets"},{"issue":"R2","key":"10.1016\/j.biopha.2020.110656_bib0060","doi-asserted-by":"crossref","first-page":"R105","DOI":"10.1093\/hmg\/ddx247","article-title":"Ageing as a risk factor for ALS\/FTD","volume":"26","author":"Niccoli","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.biopha.2020.110656_bib0065","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.arr.2016.09.006","article-title":"Dysfunction of the neurovascular unit in ischemic stroke and neurodegenerative diseases: an aging effect","volume":"34","author":"Cai","year":"2017","journal-title":"Ageing Res. Rev."},{"issue":"5","key":"10.1016\/j.biopha.2020.110656_bib0070","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.bbadis.2015.12.016","article-title":"Neurovascular dysfunction and neurodegeneration in dementia and Alzheimer\u2019s disease","volume":"1862","author":"Nelson","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"issue":"12","key":"10.1016\/j.biopha.2020.110656_bib0075","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/nrn3114","article-title":"Neurovascular pathways to neurodegeneration in Alzheimer\u2019s disease and other disorders","volume":"12","author":"Zlokovic","year":"2011","journal-title":"Nat. Rev. Neurosci."},{"issue":"10","key":"10.1016\/j.biopha.2020.110656_bib0080","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.tem.2019.07.012","article-title":"A possible neurodegeneration mechanism triggered by diabetes","volume":"30","author":"Farhadi","year":"2019","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.biopha.2020.110656_bib0085","doi-asserted-by":"crossref","first-page":"4981814","DOI":"10.1155\/2020\/4981814","article-title":"Metabolism: a novel shared link between diabetes mellitus and Alzheimer\u2019s disease","volume":"2020","author":"Sun","year":"2020","journal-title":"J. Diabetes Res."},{"issue":"3","key":"10.1016\/j.biopha.2020.110656_bib0090","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3109\/15622975.2011.650204","article-title":"Alzheimer\u2019s disease and type 2 diabetes: two diseases, one common link?","volume":"14","author":"Bartl","year":"2013","journal-title":"World J. Biol. Psychiatry"},{"issue":"3 Suppl","key":"10.1016\/j.biopha.2020.110656_bib0095","first-page":"S2","article-title":"The neurovascular unit in health and disease: introduction","volume":"40","author":"Lo","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.biopha.2020.110656_bib0100","doi-asserted-by":"crossref","DOI":"10.1161\/STROKEAHA.120.029270","article-title":"Letter by Zhou et al. regarding article, \"Brain Cleanup as a Potential Target for Poststroke Recovery: The Role of RXR (Retinoic X Receptor) in Phagocytes\"","author":"Zhou","year":"2020","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.biopha.2020.110656_bib0105","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1460-9568.2011.07738.x","article-title":"Astrocytes in the aging brain express characteristics of senescence-associated secretory phenotype","volume":"34","author":"Salminen","year":"2011","journal-title":"Eur. J. Neurosci."},{"issue":"1","key":"10.1016\/j.biopha.2020.110656_bib0110","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12964-020-00549-2","article-title":"Dual roles of astrocytes in plasticity and reconstruction after traumatic brain injury","volume":"18","author":"Zhou","year":"2020","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.biopha.2020.110656_bib0115","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1146\/annurev-physiol-022516-034406","article-title":"Microglia in physiology and disease","volume":"79","author":"Wolf","year":"2017","journal-title":"Annu. Rev. Physiol."},{"issue":"3","key":"10.1016\/j.biopha.2020.110656_bib0120","doi-asserted-by":"crossref","DOI":"10.3390\/cells9030600","article-title":"Astrocyte and oligodendrocyte cross-talk in the central nervous system","volume":"9","author":"Nutma","year":"2020","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.biopha.2020.110656_bib0125","doi-asserted-by":"crossref","first-page":"502","DOI":"10.2174\/1567202616666191026122642","article-title":"The neurovascular unit: focus on the regulation of arterial smooth muscle cells","volume":"16","author":"Quelhas","year":"2019","journal-title":"Curr. Neurovasc. Res."},{"issue":"4","key":"10.1016\/j.biopha.2020.110656_bib0130","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1215\/S1152851705000232","article-title":"The role of pericytes in blood-vessel formation and maintenance","volume":"7","author":"Bergers","year":"2005","journal-title":"Neuro Oncol."},{"issue":"2","key":"10.1016\/j.biopha.2020.110656_bib0135","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1179\/016164111X12881719352138","article-title":"Endothelin and the neurovascular unit in pediatric traumatic brain injury","volume":"33","author":"Armstead","year":"2011","journal-title":"Neurol. Res."},{"issue":"3","key":"10.1016\/j.biopha.2020.110656_bib0140","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.pneurobio.2007.12.001","article-title":"Immunosuppression after traumatic or ischemic CNS damage: it is neuroprotective and illuminates the role of microglial cells","volume":"84","author":"Hailer","year":"2008","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.biopha.2020.110656_bib0145","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.neuroscience.2014.10.035","article-title":"Caveolin expression changes in the neurovascular unit after juvenile traumatic brain injury: signs of blood-brain barrier healing?","volume":"285","author":"Badaut","year":"2015","journal-title":"Neuroscience"},{"issue":"4","key":"10.1016\/j.biopha.2020.110656_bib0150","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.tins.2005.02.001","article-title":"Neurovascular mechanisms of Alzheimer\u2019s neurodegeneration","volume":"28","author":"Zlokovic","year":"2005","journal-title":"Trends Neurosci."},{"issue":"1","key":"10.1016\/j.biopha.2020.110656_bib0155","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s00702-011-0684-8","article-title":"Evidence for angiogenesis in Parkinson\u2019s disease, incidental Lewy body disease, and progressive supranuclear palsy","volume":"119","author":"Desai Bradaric","year":"2012","journal-title":"J. Neural Transm. (Vienna)"},{"issue":"9157","key":"10.1016\/j.biopha.2020.110656_bib0160","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/S0140-6736(99)00641-8","article-title":"Blood vessels change in the mesencephalon of patients with Parkinson\u2019s disease","volume":"353","author":"Faucheux","year":"1999","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.biopha.2020.110656_bib0165","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.tins.2017.04.001","article-title":"The role of astrocyte dysfunction in parkinson\u2019s disease pathogenesis","volume":"40","author":"Booth","year":"2017","journal-title":"Trends Neurosci."},{"issue":"11","key":"10.1016\/j.biopha.2020.110656_bib0170","doi-asserted-by":"crossref","first-page":"E1035","DOI":"10.1073\/pnas.1401595111","article-title":"Blood-spinal cord barrier disruption contributes to early motor-neuron degeneration in ALS-model mice","volume":"111","author":"Winkler","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biopha.2020.110656_bib0175","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.expneurol.2013.08.019","article-title":"Neurovascular abnormalities in humans and mice with Huntington\u2019s disease","volume":"250","author":"Lin","year":"2013","journal-title":"Exp. Neurol."},{"issue":"2","key":"10.1016\/j.biopha.2020.110656_bib0180","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/ana.24406","article-title":"Cerebrovascular and blood-brain barrier impairments in Huntington\u2019s disease: potential implications for its pathophysiology","volume":"78","author":"Drouin-Ouellet","year":"2015","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.biopha.2020.110656_bib0185","article-title":"Immunometabolic changes in glia - a potential role in the pathophysiology of obesity and diabetes","author":"Robb","year":"2019","journal-title":"Neuroscience"},{"issue":"4","key":"10.1016\/j.biopha.2020.110656_bib0190","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci9040083","article-title":"Hypothesis: astrocyte foot processes detachment from the neurovascular unit in female diabetic mice may impair modulation of information processing-six degrees of separation","volume":"9","author":"Hayden","year":"2019","journal-title":"Brain Sci."},{"issue":"10","key":"10.1016\/j.biopha.2020.110656_bib0195","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci9100262","article-title":"Type 2 diabetes mellitus increases the risk of late-onset alzheimer\u2019s disease: ultrastructural remodeling of the neurovascular unit and diabetic gliopathy","volume":"9","author":"Hayden","year":"2019","journal-title":"Brain Sci."},{"issue":"3 Suppl","key":"10.1016\/j.biopha.2020.110656_bib0200","first-page":"S4","article-title":"Dysfunctional cell-cell signaling in the neurovascular unit as a paradigm for central nervous system disease","volume":"40","author":"Guo","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.biopha.2020.110656_bib0205","doi-asserted-by":"crossref","first-page":"719","DOI":"10.3389\/fendo.2019.00719","article-title":"Overexpression of miR-146a might regulate polarization transitions of BV-2 cells induced by high glucose and glucose fluctuations","volume":"10","author":"Huang","year":"2019","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.biopha.2020.110656_bib0210","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.neuroscience.2014.12.054","article-title":"Type 2 diabetes reduces the proliferation and survival of oligodendrocyte progenitor cells in ishchemic white matter lesions","volume":"289","author":"Yatomi","year":"2015","journal-title":"Neuroscience"},{"issue":"10","key":"10.1016\/j.biopha.2020.110656_bib0215","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1161\/STROKEAHA.118.021452","article-title":"Diabetes mellitus impairs white matter repair and long-term functional deficits after cerebral ischemia","volume":"49","author":"Ma","year":"2018","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.biopha.2020.110656_bib0220","doi-asserted-by":"crossref","first-page":"R149","DOI":"10.1152\/ajpregu.00088.2019","article-title":"Endothelium-dependent impairments to cerebral vascular reactivity with type 2 diabetes mellitus in the Goto-Kakizaki rat","volume":"317","author":"Halvorson","year":"2019","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"issue":"10","key":"10.1016\/j.biopha.2020.110656_bib0225","first-page":"2290","article-title":"The protective role of Sirt1 in vascular tissue: its relationship to vascular aging and atherosclerosis","volume":"8","author":"Kitada","year":"2016","journal-title":"Aging (Albany N. Y.)"},{"issue":"1","key":"10.1016\/j.biopha.2020.110656_bib0230","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1038\/s41598-019-39230-1","article-title":"Leptin receptor deficiency induces early, transient and hyperglycaemia-independent blood-brain barrier dysfunction","volume":"9","author":"Corem","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2020.110656_bib0235","doi-asserted-by":"crossref","first-page":"104580","DOI":"10.1016\/j.nbd.2019.104580","article-title":"Obesity-related cognitive impairment: the role of endothelial dysfunction","volume":"132","author":"Buie","year":"2019","journal-title":"Neurobiol. Dis."},{"issue":"3","key":"10.1016\/j.biopha.2020.110656_bib0240","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1124\/jpet.116.237057","article-title":"Blood-brain barrier disruption and neurovascular unit dysfunction in diabetic mice: protection with the mitochondrial carbonic anhydrase inhibitor topiramate","volume":"359","author":"Salameh","year":"2016","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"2","key":"10.1016\/j.biopha.2020.110656_bib0245","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1177\/0271678X15610340","article-title":"What is a pericyte?","volume":"36","author":"Attwell","year":"2016","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"1","key":"10.1016\/j.biopha.2020.110656_bib0250","doi-asserted-by":"crossref","first-page":"17462","DOI":"10.1038\/s41598-018-35576-0","article-title":"Prolonged systemic hyperglycemia does not cause pericyte loss and permeability at the mouse blood-brain barrier","volume":"8","author":"Mae","year":"2018","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.biopha.2020.110656_bib0255","doi-asserted-by":"crossref","first-page":"e0177447","DOI":"10.1371\/journal.pone.0177447","article-title":"Contribution of thrombin-reactive brain pericytes to blood-brain barrier dysfunction in an in vivo mouse model of obesity-associated diabetes and an in vitro rat model","volume":"12","author":"Machida","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2020.110656_bib0260","doi-asserted-by":"crossref","first-page":"2537698","DOI":"10.1155\/2019\/2537698","article-title":"Pathomechanisms of blood-brain barrier disruption in ALS","volume":"2019","author":"Kakaroubas","year":"2019","journal-title":"Neurosci. J."},{"issue":"2","key":"10.1016\/j.biopha.2020.110656_bib0265","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0006-8993(02)03294-8","article-title":"Blood-brain barrier integrity is unaltered in human brain cortex with diabetes mellitus","volume":"954","author":"Dai","year":"2002","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.biopha.2020.110656_bib0270","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1136\/jnnp.74.1.70","article-title":"Increased blood-brain barrier permeability in type II diabetes demonstrated by gadolinium magnetic resonance imaging","volume":"74","author":"Starr","year":"2003","journal-title":"J. Neurol. Neurosurg Psychiatry"},{"issue":"3","key":"10.1016\/j.biopha.2020.110656_bib0275","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1023\/A:1014892706696","article-title":"Diabetes-related changes in rat cerebral occludin and zonula occludens-1 (ZO-1) expression","volume":"27","author":"Chehade","year":"2002","journal-title":"Neurochem. Res."},{"issue":"1","key":"10.1016\/j.biopha.2020.110656_bib0280","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s00125-006-0485-z","article-title":"Increased blood-brain barrier permeability and altered tight junctions in experimental diabetes in the rat: contribution of hyperglycaemia and matrix metalloproteinases","volume":"50","author":"Hawkins","year":"2007","journal-title":"Diabetologia"},{"issue":"8","key":"10.1016\/j.biopha.2020.110656_bib0285","doi-asserted-by":"crossref","first-page":"e20599","DOI":"10.1371\/journal.pone.0020599","article-title":"Matrix metalloproteinase-2 and -9 secreted by leukemic cells increase the permeability of blood-brain barrier by disrupting tight junction proteins","volume":"6","author":"Feng","year":"2011","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.biopha.2020.110656_bib0290","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1007\/s12035-018-1234-2","article-title":"Recombinant FGF21 protects against blood-brain barrier leakage through Nrf2 upregulation in type 2 diabetes mice","volume":"56","author":"Yu","year":"2019","journal-title":"Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.biopha.2020.110656_bib0295","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s12974-019-1495-3","article-title":"HDAC3 inhibition prevents blood-brain barrier permeability through Nrf2 activation in type 2 diabetes male mice","volume":"16","author":"Zhao","year":"2019","journal-title":"J. Neuroinflammation"},{"issue":"8","key":"10.1016\/j.biopha.2020.110656_bib0300","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1002\/syn.20644","article-title":"Upregulation of RAGE at the blood-brain barrier in streptozotocin-induced diabetic mice","volume":"63","author":"Liu","year":"2009","journal-title":"Synapse"},{"issue":"6\u20137","key":"10.1016\/j.biopha.2020.110656_bib0305","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.neuropharm.2009.03.001","article-title":"Downregulation of LRP1 [correction of LPR1] at the blood-brain barrier in streptozotocin-induced diabetic mice","volume":"56","author":"Hong","year":"2009","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.biopha.2020.110656_bib0310","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.brainres.2006.09.061","article-title":"Impaired function and expression of P-glycoprotein in blood-brain barrier of streptozotocin-induced diabetic rats","volume":"1123","author":"Liu","year":"2006","journal-title":"Brain Res."},{"issue":"10","key":"10.1016\/j.biopha.2020.110656_bib0315","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s11095-019-2674-8","article-title":"Changes of blood-brain barrier and brain parenchymal protein expression levels of mice under different insulin-resistance conditions induced by high-fat diet","volume":"36","author":"Ogata","year":"2019","journal-title":"Pharm. Res."},{"issue":"8","key":"10.1016\/j.biopha.2020.110656_bib0320","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/j.1755-5949.2012.00341.x","article-title":"PPARgamma agonist pioglitazone reverses memory impairment and biochemical changes in a mouse model of type 2 diabetes mellitus","volume":"18","author":"Jiang","year":"2012","journal-title":"CNS Neurosci. Ther."},{"issue":"2","key":"10.1016\/j.biopha.2020.110656_bib0325","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/bph.13378","article-title":"PPARgamma agonists regulate bidirectional transport of amyloid-beta across the blood-brain barrier and hippocampus plasticity in db\/db mice","volume":"173","author":"Wang","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.biopha.2020.110656_bib0330","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.neuropharm.2015.07.023","article-title":"Antidiabetic drugs restore abnormal transport of amyloid-beta across the blood-brain barrier and memory impairment in db\/db mice","volume":"101","author":"Chen","year":"2016","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.biopha.2020.110656_bib0335","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.tins.2008.11.005","article-title":"Astrocytes and the regulation of cerebral blood flow","volume":"32","author":"Koehler","year":"2009","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.biopha.2020.110656_bib0340","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.neuroscience.2015.03.064","article-title":"Beyond neurovascular coupling, role of astrocytes in the regulation of vascular tone","volume":"323","author":"Filosa","year":"2016","journal-title":"Neuroscience"},{"issue":"4","key":"10.1016\/j.biopha.2020.110656_bib0345","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1111\/apha.12250","article-title":"The neurovascular unit - concept review","volume":"210","author":"Muoio","year":"2014","journal-title":"Acta Physiol. (Oxf)"},{"issue":"7","key":"10.1016\/j.biopha.2020.110656_bib0350","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/nrn.2017.48","article-title":"Cerebral blood flow regulation and neurovascular dysfunction in Alzheimer disease","volume":"18","author":"Kisler","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"issue":"3","key":"10.1016\/j.biopha.2020.110656_bib0355","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.neuroimage.2005.10.029","article-title":"Brain hemodynamic changes mediated by dopamine receptors: role of the cerebral microvasculature in dopamine-mediated neurovascular coupling","volume":"30","author":"Choi","year":"2006","journal-title":"Neuroimage"},{"issue":"2","key":"10.1016\/j.biopha.2020.110656_bib0360","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1124\/jpet.111.191296","article-title":"Cerebral myogenic reactivity and blood flow in type 2 diabetic rats: role of peroxynitrite in hypoxia-mediated loss of myogenic tone","volume":"342","author":"Kelly-Cobbs","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"5","key":"10.1016\/j.biopha.2020.110656_bib0365","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1007\/s11682-016-9583-9","article-title":"Cerebral perfusion alterations in type 2 diabetes and its relation to insulin resistance and cognitive dysfunction","volume":"11","author":"Cui","year":"2017","journal-title":"Brain Imaging Behav."},{"key":"10.1016\/j.biopha.2020.110656_bib0370","doi-asserted-by":"crossref","first-page":"102302","DOI":"10.1016\/j.nicl.2020.102302","article-title":"Impaired cerebral blood flow in type 2 diabetes mellitus - A comparative study with subjective cognitive decline, vascular dementia and Alzheimer\u2019s disease subjects","volume":"27","author":"Chau","year":"2020","journal-title":"Neuroimage Clin."},{"key":"10.1016\/j.biopha.2020.110656_bib0375","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3389\/fnagi.2018.00270","article-title":"Reduced regional cerebral blood flow relates to poorer cognition in older adults with type 2 diabetes","volume":"10","author":"Bangen","year":"2018","journal-title":"Front. Aging Neurosci."},{"issue":"3","key":"10.1016\/j.biopha.2020.110656_bib0380","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","article-title":"Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders","volume":"14","author":"Sweeney","year":"2018","journal-title":"Nat. Rev. Neurol."},{"issue":"2","key":"10.1016\/j.biopha.2020.110656_bib0385","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neuron.2008.01.003","article-title":"The blood-brain barrier in health and chronic neurodegenerative disorders","volume":"57","author":"Zlokovic","year":"2008","journal-title":"Neuron"},{"issue":"7","key":"10.1016\/j.biopha.2020.110656_bib0390","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.2967\/jnumed.113.130161","article-title":"Activity of P-glycoprotein, a beta-amyloid transporter at the blood-brain barrier, is compromised in patients with mild alzheimer disease","volume":"55","author":"Deo","year":"2014","journal-title":"J. Nucl. Med."},{"issue":"6","key":"10.1016\/j.biopha.2020.110656_bib0395","doi-asserted-by":"crossref","first-page":"615","DOI":"10.2174\/1567205013666160314151012","article-title":"A role for P-glycoprotein in clearance of alzheimer amyloid beta -Peptide from the brain","volume":"13","author":"Wang","year":"2016","journal-title":"Curr. Alzheimer Res."},{"issue":"9","key":"10.1016\/j.biopha.2020.110656_bib0400","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/nm1287","article-title":"Role of the MEOX2 homeobox gene in neurovascular dysfunction in Alzheimer disease","volume":"11","author":"Wu","year":"2005","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.biopha.2020.110656_bib0405","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1136\/jnnp-2017-316011","article-title":"Vascular pathology in multiple sclerosis: reframing pathogenesis around the blood-brain barrier","volume":"89","author":"Spencer","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"1","key":"10.1016\/j.biopha.2020.110656_bib0410","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1365-2990.2006.00781.x","article-title":"Persistent endothelial abnormalities and blood-brain barrier leak in primary and secondary progressive multiple sclerosis","volume":"33","author":"Leech","year":"2007","journal-title":"Neuropathol. Appl. Neurobiol."},{"issue":"3","key":"10.1016\/j.biopha.2020.110656_bib0415","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.neuroscience.2007.04.051","article-title":"Inflammation and dephosphorylation of the tight junction protein occludin in an experimental model of multiple sclerosis","volume":"147","author":"Morgan","year":"2007","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/j.biopha.2020.110656_bib0420","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/glia.20599","article-title":"Transplanted astrocytes internalize deposited beta-amyloid peptides in a transgenic mouse model of Alzheimer\u2019s disease","volume":"56","author":"Pihlaja","year":"2008","journal-title":"Glia"},{"issue":"11","key":"10.1016\/j.biopha.2020.110656_bib0425","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1002\/glia.21212","article-title":"Multiple cellular and molecular mechanisms are involved in human Abeta clearance by transplanted adult astrocytes","volume":"59","author":"Pihlaja","year":"2011","journal-title":"Glia"},{"key":"10.1016\/j.biopha.2020.110656_bib0430","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3389\/fnmol.2017.00427","article-title":"Involvement of astrocytes in alzheimer\u2019s disease from a neuroinflammatory and oxidative stress perspective","volume":"10","author":"Gonzalez-Reyes","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.biopha.2020.110656_bib0435","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3389\/fimmu.2018.00217","article-title":"The role of astrocytes in multiple sclerosis","volume":"9","author":"Ponath","year":"2018","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.biopha.2020.110656_bib0440","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1038\/s41590-018-0212-1","article-title":"The identity and function of microglia in neurodegeneration","volume":"19","author":"Song","year":"2018","journal-title":"Nat. Immunol."},{"issue":"5","key":"10.1016\/j.biopha.2020.110656_bib0445","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3109\/00207454.2013.833510","article-title":"Microglia, neuroinflammation, and beta-amyloid protein in Alzheimer\u2019s disease","volume":"124","author":"Cai","year":"2014","journal-title":"Int. J. Neurosci."},{"issue":"11","key":"10.1016\/j.biopha.2020.110656_bib0450","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.02.025","article-title":"Beta-amyloid clustering around ASC fibrils boosts its toxicity in microglia","volume":"30","author":"Friker","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.biopha.2020.110656_bib0455","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.neulet.2016.07.052","article-title":"Significance of aberrant glial cell phenotypes in pathophysiology of amyotrophic lateral sclerosis","volume":"636","author":"Trias","year":"2017","journal-title":"Neurosci. Lett."},{"issue":"2","key":"10.1016\/j.biopha.2020.110656_bib0460","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa1211103","article-title":"Variant of TREM2 associated with the risk of Alzheimer\u2019s disease","volume":"368","author":"Jonsson","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.biopha.2020.110656_bib0465","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.neuron.2013.04.014","article-title":"Alzheimer\u2019s disease risk gene CD33 inhibits microglial uptake of amyloid beta","volume":"78","author":"Griciuc","year":"2013","journal-title":"Neuron"},{"issue":"4","key":"10.1016\/j.biopha.2020.110656_bib0470","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1001\/jamaneurol.2013.6237","article-title":"TREM2 variant p.R47H as a risk factor for sporadic amyotrophic lateral sclerosis","volume":"71","author":"Cady","year":"2014","journal-title":"JAMA Neurol."},{"issue":"12","key":"10.1016\/j.biopha.2020.110656_bib0475","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1038\/ng.2802","article-title":"Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer\u2019s disease","volume":"45","author":"Lambert","year":"2013","journal-title":"Nat. Genet."},{"issue":"6","key":"10.1016\/j.biopha.2020.110656_bib0480","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19061743","article-title":"Molecular mechanisms of oligodendrocyte regeneration in white matter-related diseases","volume":"19","author":"Ohtomo","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2020.110656_bib0485","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s40478-018-0515-3","article-title":"White matter changes in Alzheimer\u2019s disease: a focus on myelin and oligodendrocytes","volume":"6","author":"Nasrabady","year":"2018","journal-title":"Acta Neuropathol. Commun."},{"issue":"5","key":"10.1016\/j.biopha.2020.110656_bib0490","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s00401-010-0657-2","article-title":"Focal demyelination in Alzheimer\u2019s disease and transgenic mouse models","volume":"119","author":"Mitew","year":"2010","journal-title":"Acta Neuropathol."},{"issue":"2","key":"10.1016\/j.biopha.2020.110656_bib0495","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/glia.22432","article-title":"Dynamic changes in myelin aberrations and oligodendrocyte generation in chronic amyloidosis in mice and men","volume":"61","author":"Behrendt","year":"2013","journal-title":"Glia"},{"issue":"Pt B","key":"10.1016\/j.biopha.2020.110656_bib0500","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.neuropharm.2016.04.026","article-title":"Contribution of the oligodendrocyte lineage to CNS repair and neurodegenerative pathologies","volume":"110","author":"Tognatta","year":"2016","journal-title":"Neuropharmacology"},{"issue":"7745","key":"10.1016\/j.biopha.2020.110656_bib0505","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/s41586-019-0903-2","article-title":"Altered human oligodendrocyte heterogeneity in multiple sclerosis","volume":"566","author":"Jakel","year":"2019","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.biopha.2020.110656_bib0510","doi-asserted-by":"crossref","first-page":"283","DOI":"10.31887\/dcns.2018.20.4\/amot","article-title":"An emerging role of dysfunctional axon-oligodendrocyte coupling in neurodegenerative diseases","volume":"20","author":"Mot","year":"2018","journal-title":"Dialogues Clin. Neurosci."},{"issue":"4","key":"10.1016\/j.biopha.2020.110656_bib0515","first-page":"197","article-title":"Evidence of endothelial dysfunction in the development of Alzheimer's disease: is Alzheimer's a vascular disorder?","volume":"3","author":"Kelleher","year":"2013","journal-title":"Am. J. Cardiovasc. Dis."},{"issue":"7","key":"10.1016\/j.biopha.2020.110656_bib0520","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S0197-4580(03)00007-1","article-title":"Increased concentrations of homocysteine and asymmetric dimethylarginine and decreased concentrations of nitric oxide in the plasma of patients with Alzheimer\u2019s disease","volume":"24","author":"Selley","year":"2003","journal-title":"Neurobiol. Aging"},{"issue":"4","key":"10.1016\/j.biopha.2020.110656_bib0525","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1177\/1073858410366481","article-title":"Nitric oxide signaling in brain function, dysfunction, and dementia","volume":"16","author":"Steinert","year":"2010","journal-title":"Neuroscientist"},{"issue":"3","key":"10.1016\/j.biopha.2020.110656_bib0530","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/bpa.12004","article-title":"Deficiency in mural vascular cells coincides with blood-brain barrier disruption in Alzheimer\u2019s disease","volume":"23","author":"Sengillo","year":"2013","journal-title":"Brain Pathol."},{"issue":"1","key":"10.1016\/j.biopha.2020.110656_bib0535","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/jcbfm.2015.44","article-title":"Accelerated pericyte degeneration and blood-brain barrier breakdown in apolipoprotein E4 carriers with Alzheimer\u2019s disease","volume":"36","author":"Halliday","year":"2016","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"3","key":"10.1016\/j.biopha.2020.110656_bib0540","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/nn.4489","article-title":"Pericyte degeneration leads to neurovascular uncoupling and limits oxygen supply to brain","volume":"20","author":"Kisler","year":"2017","journal-title":"Nat. Neurosci."},{"issue":"6","key":"10.1016\/j.biopha.2020.110656_bib0545","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/nn.4288","article-title":"Pericytes of the neurovascular unit: key functions and signaling pathways","volume":"19","author":"Sweeney","year":"2016","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.biopha.2020.110656_bib0550","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1093\/epirev\/mxs012","article-title":"Type 2 diabetes as a risk factor for Alzheimer\u2019s disease: the confounders, interactions, and neuropathology associated with this relationship","volume":"35","author":"Vagelatos","year":"2013","journal-title":"Epidemiol. Rev."},{"key":"10.1016\/j.biopha.2020.110656_bib0555","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.diabres.2016.10.024","article-title":"An updated meta-analysis of cohort studies: diabetes and risk of Alzheimer\u2019s disease","volume":"124","author":"Zhang","year":"2017","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.biopha.2020.110656_bib0560","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.neubiorev.2016.03.005","article-title":"Diabetes and Alzheimer\u2019s disease crosstalk","volume":"64","author":"Baglietto-Vargas","year":"2016","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.biopha.2020.110656_bib0565","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.neuint.2017.04.020","article-title":"Bidirectional interactions between diabetes and Alzheimer\u2019s disease","volume":"108","author":"Shinohara","year":"2017","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.biopha.2020.110656_bib0570","doi-asserted-by":"crossref","first-page":"549","DOI":"10.2147\/CIA.S74042","article-title":"Link between type 2 diabetes and Alzheimer\u2019s disease: from epidemiology to mechanism and treatment","volume":"10","author":"Li","year":"2015","journal-title":"Clin. Interv. Aging"},{"issue":"2","key":"10.1016\/j.biopha.2020.110656_bib0575","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1212\/WNL.0000000000005771","article-title":"Association between diabetes and subsequent Parkinson disease: a record-linkage cohort study","volume":"91","author":"De Pablo-Fernandez","year":"2018","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.biopha.2020.110656_bib0580","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.2337\/dc08-0688","article-title":"Prospective cohort study of type 2 diabetes and the risk of Parkinson\u2019s disease","volume":"31","author":"Driver","year":"2008","journal-title":"Diabetes Care"},{"issue":"19","key":"10.1016\/j.biopha.2020.110656_bib0585","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1212\/WNL.0b013e3182553cc9","article-title":"Clinical features of Parkinson disease when onset of diabetes came first: a case-control study","volume":"78","author":"Cereda","year":"2012","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.biopha.2020.110656_bib0590","doi-asserted-by":"crossref","DOI":"10.3390\/cells8090962","article-title":"Mutant huntingtin affects diabetes and alzheimer\u2019s markers in human and cell models of Huntington\u2019s disease","volume":"8","author":"Chaves","year":"2019","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.biopha.2020.110656_bib0595","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3233\/JHD-190366","article-title":"Glycation in Huntington\u2019s disease: a possible modifier and target for intervention","volume":"8","author":"Bras","year":"2019","journal-title":"J. Huntingtons Dis."},{"issue":"Pt B","key":"10.1016\/j.biopha.2020.110656_bib0600","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.pnpbp.2017.06.002","article-title":"Effects of metformin exposure on neurodegenerative diseases in elderly patients with type 2 diabetes mellitus","volume":"79","author":"Kuan","year":"2017","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.biopha.2020.110656_bib0605","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.3233\/JAD-180263","article-title":"Metformin use associated with reduced risk of dementia in patients with diabetes: a systematic review and meta-analysis","volume":"65","author":"Campbell","year":"2018","journal-title":"J. Alzheimers Dis."},{"issue":"1","key":"10.1016\/j.biopha.2020.110656_bib0610","doi-asserted-by":"crossref","first-page":"e000563","DOI":"10.1136\/bmjdrc-2018-000563","article-title":"Impact of pharmacological treatment of diabetes mellitus on dementia risk: systematic review and meta-analysis","volume":"6","author":"McMillan","year":"2018","journal-title":"BMJ Open Diabetes Res. Care"},{"issue":"5","key":"10.1016\/j.biopha.2020.110656_bib0615","doi-asserted-by":"crossref","first-page":"949","DOI":"10.14336\/AD.2019.0120","article-title":"Metformin alters locomotor and cognitive function and brain metabolism in normoglycemic mice","volume":"10","author":"Li","year":"2019","journal-title":"Aging Dis."},{"issue":"3","key":"10.1016\/j.biopha.2020.110656_bib0620","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.dsx.2018.03.002","article-title":"Glucagon like peptide-1 (GLP-1) likes Alzheimer\u2019s disease","volume":"12","author":"Yildirim Simsir","year":"2018","journal-title":"Diabetes Metab. Syndr."},{"issue":"Pt B","key":"10.1016\/j.biopha.2020.110656_bib0625","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.neuropharm.2017.09.023","article-title":"Protective effects of the GLP-1 mimetic exendin-4 in Parkinson\u2019s disease","volume":"136","author":"Athauda","year":"2018","journal-title":"Neuropharmacology"},{"issue":"7","key":"10.1016\/j.biopha.2020.110656_bib0630","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/nn.2583","article-title":"Amyloid-beta-induced neuronal dysfunction in Alzheimer\u2019s disease: from synapses toward neural networks","volume":"13","author":"Palop","year":"2010","journal-title":"Nat. Neurosci."},{"issue":"11","key":"10.1016\/j.biopha.2020.110656_bib0635","doi-asserted-by":"crossref","first-page":"3482","DOI":"10.2337\/db16-0556","article-title":"F1F0 ATP synthase-cyclophilin d interaction contributes to diabetes-induced synaptic dysfunction and cognitive decline","volume":"65","author":"Yan","year":"2016","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.biopha.2020.110656_bib0640","doi-asserted-by":"crossref","first-page":"645","DOI":"10.2337\/db13-1063","article-title":"Epigenetic mechanisms linking diabetes and synaptic impairments","volume":"63","author":"Wang","year":"2014","journal-title":"Diabetes"},{"issue":"43","key":"10.1016\/j.biopha.2020.110656_bib0645","doi-asserted-by":"crossref","first-page":"10939","DOI":"10.1523\/JNEUROSCI.2085-06.2006","article-title":"Matrix metalloproteinases expressed by astrocytes mediate extracellular amyloid-beta peptide catabolism","volume":"26","author":"Yin","year":"2006","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.biopha.2020.110656_bib0650","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1096\/fj.12-208660","article-title":"Attenuating astrocyte activation accelerates plaque pathogenesis in APP\/PS1 mice","volume":"27","author":"Kraft","year":"2013","journal-title":"FASEB J."},{"issue":"13","key":"10.1016\/j.biopha.2020.110656_bib0655","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1212\/WNL.0000000000001982","article-title":"Type 2 diabetes mellitus and biomarkers of neurodegeneration","volume":"85","author":"Moran","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.biopha.2020.110656_bib0660","doi-asserted-by":"crossref","first-page":"383","DOI":"10.3389\/fnins.2018.00383","article-title":"Alzheimer\u2019s disease and type 2 diabetes: a critical assessment of the shared pathological traits","volume":"12","author":"Chatterjee","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.biopha.2020.110656_bib0665","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.1038\/ncomms3932","article-title":"Pericyte loss influences Alzheimer-like neurodegeneration in mice","volume":"4","author":"Sagare","year":"2013","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.biopha.2020.110656_bib0670","doi-asserted-by":"crossref","first-page":"790","DOI":"10.2174\/1567205014666170203143336","article-title":"Tauopathies - focus on changes at the neurovascular unit","volume":"14","author":"Michalicova","year":"2017","journal-title":"Curr. Alzheimer Res."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332220308490?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332220308490?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T18:48:18Z","timestamp":1766083698000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332220308490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":134,"alternative-id":["S0753332220308490"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2020.110656","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dysfunction of the neurovascular unit in diabetes-related neurodegeneration","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2020.110656","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"110656"}}